Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model Article Swipe
Yuki Narita
,
Miki Ueda
,
Kohei Uchimura
,
Yutaka Kakizoe
,
Yoshikazu Miyasato
,
Teruhiko Mizumoto
,
Jun Morinaga
,
Manabu Hayata
,
Terumasa Nakagawa
,
Masataka Adachi
,
Taku Miyoshi
,
Yoshiki Sakai
,
Daisuke Kadowaki
,
Sumío Hirata
,
Masashi Mukoyama
,
Kenichiro Kitamura
·
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1016/j.jphs.2016.01.003
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1016/j.jphs.2016.01.003
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jphs.2016.01.003
- OA Status
- gold
- Cited By
- 13
- References
- 28
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2278052728
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2278052728Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jphs.2016.01.003Digital Object Identifier
- Title
-
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease modelWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2016Year of publication
- Publication date
-
2016-01-20Full publication date if available
- Authors
-
Yuki Narita, Miki Ueda, Kohei Uchimura, Yutaka Kakizoe, Yoshikazu Miyasato, Teruhiko Mizumoto, Jun Morinaga, Manabu Hayata, Terumasa Nakagawa, Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Daisuke Kadowaki, Sumío Hirata, Masashi Mukoyama, Kenichiro KitamuraList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jphs.2016.01.003Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.jphs.2016.01.003Direct OA link when available
- Concepts
-
Telmisartan, Endocrinology, Combination therapy, Renal function, Internal medicine, Pharmacology, Aldosterone, Plasma renin activity, Creatinine, Kidney disease, Medicine, ACE inhibitor, Renin–angiotensin system, Chemistry, Urology, Blood pressure, Angiotensin-converting enzymeTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
13Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2022: 3, 2021: 1, 2020: 1, 2019: 3Per-year citation counts (last 5 years)
- References (count)
-
28Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2278052728 |
|---|---|
| doi | https://doi.org/10.1016/j.jphs.2016.01.003 |
| ids.doi | https://doi.org/10.1016/j.jphs.2016.01.003 |
| ids.mag | 2278052728 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/26887332 |
| ids.openalex | https://openalex.org/W2278052728 |
| fwci | 1.55322948 |
| mesh[0].qualifier_ui | Q000097 |
| mesh[0].descriptor_ui | D000450 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | blood |
| mesh[0].descriptor_name | Aldosterone |
| mesh[1].qualifier_ui | Q000008 |
| mesh[1].descriptor_ui | D047228 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | administration & dosage |
| mesh[1].descriptor_name | Angiotensin II Type 1 Receptor Blockers |
| mesh[2].qualifier_ui | Q000494 |
| mesh[2].descriptor_ui | D047228 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | pharmacology |
| mesh[2].descriptor_name | Angiotensin II Type 1 Receptor Blockers |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D000959 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Antihypertensive Agents |
| mesh[5].qualifier_ui | Q000494 |
| mesh[5].descriptor_ui | D000959 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | pharmacology |
| mesh[5].descriptor_name | Antihypertensive Agents |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D001562 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Benzimidazoles |
| mesh[7].qualifier_ui | Q000494 |
| mesh[7].descriptor_ui | D001562 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | pharmacology |
| mesh[7].descriptor_name | Benzimidazoles |
| mesh[8].qualifier_ui | Q000008 |
| mesh[8].descriptor_ui | D001565 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | administration & dosage |
| mesh[8].descriptor_name | Benzoates |
| mesh[9].qualifier_ui | Q000494 |
| mesh[9].descriptor_ui | D001565 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pharmacology |
| mesh[9].descriptor_name | Benzoates |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D001794 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | Blood Pressure |
| mesh[11].qualifier_ui | Q000097 |
| mesh[11].descriptor_ui | D003404 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | blood |
| mesh[11].descriptor_name | Creatinine |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D004195 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Disease Models, Animal |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D004359 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Drug Therapy, Combination |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D004952 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Esters |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D005355 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Fibrosis |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D016670 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Gabexate |
| mesh[17].qualifier_ui | Q000031 |
| mesh[17].descriptor_ui | D016670 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | analogs & derivatives |
| mesh[17].descriptor_name | Gabexate |
| mesh[18].qualifier_ui | Q000494 |
| mesh[18].descriptor_ui | D016670 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | pharmacology |
| mesh[18].descriptor_name | Gabexate |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006146 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Guanidines |
| mesh[20].qualifier_ui | Q000473 |
| mesh[20].descriptor_ui | D007668 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | pathology |
| mesh[20].descriptor_name | Kidney |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008297 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Male |
| mesh[22].qualifier_ui | Q000187 |
| mesh[22].descriptor_ui | D018384 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | drug effects |
| mesh[22].descriptor_name | Oxidative Stress |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D017207 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Rats, Sprague-Dawley |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D051436 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Renal Insufficiency, Chronic |
| mesh[25].qualifier_ui | Q000097 |
| mesh[25].descriptor_ui | D012083 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | blood |
| mesh[25].descriptor_name | Renin |
| mesh[26].qualifier_ui | Q000187 |
| mesh[26].descriptor_ui | D012084 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | drug effects |
| mesh[26].descriptor_name | Renin-Angiotensin System |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D015842 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Serine Proteinase Inhibitors |
| mesh[28].qualifier_ui | Q000494 |
| mesh[28].descriptor_ui | D015842 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | pharmacology |
| mesh[28].descriptor_name | Serine Proteinase Inhibitors |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000077333 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Telmisartan |
| mesh[30].qualifier_ui | Q000097 |
| mesh[30].descriptor_ui | D000450 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | blood |
| mesh[30].descriptor_name | Aldosterone |
| mesh[31].qualifier_ui | Q000008 |
| mesh[31].descriptor_ui | D047228 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | administration & dosage |
| mesh[31].descriptor_name | Angiotensin II Type 1 Receptor Blockers |
| mesh[32].qualifier_ui | Q000494 |
| mesh[32].descriptor_ui | D047228 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | pharmacology |
| mesh[32].descriptor_name | Angiotensin II Type 1 Receptor Blockers |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D000818 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Animals |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D000959 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | Antihypertensive Agents |
| mesh[35].qualifier_ui | Q000494 |
| mesh[35].descriptor_ui | D000959 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | pharmacology |
| mesh[35].descriptor_name | Antihypertensive Agents |
| mesh[36].qualifier_ui | Q000008 |
| mesh[36].descriptor_ui | D001562 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | administration & dosage |
| mesh[36].descriptor_name | Benzimidazoles |
| mesh[37].qualifier_ui | Q000494 |
| mesh[37].descriptor_ui | D001562 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | pharmacology |
| mesh[37].descriptor_name | Benzimidazoles |
| mesh[38].qualifier_ui | Q000008 |
| mesh[38].descriptor_ui | D001565 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | administration & dosage |
| mesh[38].descriptor_name | Benzoates |
| mesh[39].qualifier_ui | Q000494 |
| mesh[39].descriptor_ui | D001565 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | pharmacology |
| mesh[39].descriptor_name | Benzoates |
| mesh[40].qualifier_ui | Q000187 |
| mesh[40].descriptor_ui | D001794 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | drug effects |
| mesh[40].descriptor_name | Blood Pressure |
| mesh[41].qualifier_ui | Q000097 |
| mesh[41].descriptor_ui | D003404 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | blood |
| mesh[41].descriptor_name | Creatinine |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D004195 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Disease Models, Animal |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D004359 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Drug Therapy, Combination |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D004952 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Esters |
| mesh[45].qualifier_ui | Q000188 |
| mesh[45].descriptor_ui | D005355 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | drug therapy |
| mesh[45].descriptor_name | Fibrosis |
| mesh[46].qualifier_ui | Q000008 |
| mesh[46].descriptor_ui | D016670 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | administration & dosage |
| mesh[46].descriptor_name | Gabexate |
| mesh[47].qualifier_ui | Q000031 |
| mesh[47].descriptor_ui | D016670 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | analogs & derivatives |
| mesh[47].descriptor_name | Gabexate |
| mesh[48].qualifier_ui | Q000494 |
| mesh[48].descriptor_ui | D016670 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | pharmacology |
| mesh[48].descriptor_name | Gabexate |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D006146 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Guanidines |
| type | article |
| title | Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model |
| biblio.issue | 2 |
| biblio.volume | 130 |
| biblio.last_page | 116 |
| biblio.first_page | 110 |
| topics[0].id | https://openalex.org/T11001 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Renin-Angiotensin System Studies |
| topics[1].id | https://openalex.org/T10144 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.998199999332428 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Blood Pressure and Hypertension Studies |
| topics[2].id | https://openalex.org/T11839 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9970999956130981 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Hormonal Regulation and Hypertension |
| funders[0].id | https://openalex.org/F4320327845 |
| funders[0].ror | https://ror.org/022jefx64 |
| funders[0].display_name | Ono Pharmaceutical |
| is_xpac | False |
| apc_list.value | 100000 |
| apc_list.currency | JPY |
| apc_list.value_usd | 753 |
| apc_paid.value | 100000 |
| apc_paid.currency | JPY |
| apc_paid.value_usd | 753 |
| concepts[0].id | https://openalex.org/C2779716603 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7361652851104736 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q733186 |
| concepts[0].display_name | Telmisartan |
| concepts[1].id | https://openalex.org/C134018914 |
| concepts[1].level | 1 |
| concepts[1].score | 0.5993908047676086 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[1].display_name | Endocrinology |
| concepts[2].id | https://openalex.org/C2776999253 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5948556065559387 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1304270 |
| concepts[2].display_name | Combination therapy |
| concepts[3].id | https://openalex.org/C159641895 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5737112760543823 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q108377937 |
| concepts[3].display_name | Renal function |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5680252909660339 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C98274493 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5658807754516602 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[5].display_name | Pharmacology |
| concepts[6].id | https://openalex.org/C2778525890 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5553829669952393 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q184564 |
| concepts[6].display_name | Aldosterone |
| concepts[7].id | https://openalex.org/C138976137 |
| concepts[7].level | 4 |
| concepts[7].score | 0.5165397524833679 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7201790 |
| concepts[7].display_name | Plasma renin activity |
| concepts[8].id | https://openalex.org/C2780306776 |
| concepts[8].level | 2 |
| concepts[8].score | 0.5124288201332092 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q426660 |
| concepts[8].display_name | Creatinine |
| concepts[9].id | https://openalex.org/C2778653478 |
| concepts[9].level | 2 |
| concepts[9].score | 0.5101495385169983 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1054718 |
| concepts[9].display_name | Kidney disease |
| concepts[10].id | https://openalex.org/C71924100 |
| concepts[10].level | 0 |
| concepts[10].score | 0.48751017451286316 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[10].display_name | Medicine |
| concepts[11].id | https://openalex.org/C2779611605 |
| concepts[11].level | 4 |
| concepts[11].score | 0.4155641496181488 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q288280 |
| concepts[11].display_name | ACE inhibitor |
| concepts[12].id | https://openalex.org/C198710026 |
| concepts[12].level | 3 |
| concepts[12].score | 0.38384518027305603 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q898218 |
| concepts[12].display_name | Renin–angiotensin system |
| concepts[13].id | https://openalex.org/C185592680 |
| concepts[13].level | 0 |
| concepts[13].score | 0.362109899520874 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[13].display_name | Chemistry |
| concepts[14].id | https://openalex.org/C126894567 |
| concepts[14].level | 1 |
| concepts[14].score | 0.32047417759895325 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q105650 |
| concepts[14].display_name | Urology |
| concepts[15].id | https://openalex.org/C84393581 |
| concepts[15].level | 2 |
| concepts[15].score | 0.28620219230651855 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q82642 |
| concepts[15].display_name | Blood pressure |
| concepts[16].id | https://openalex.org/C27016395 |
| concepts[16].level | 3 |
| concepts[16].score | 0.2520042061805725 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q128861 |
| concepts[16].display_name | Angiotensin-converting enzyme |
| keywords[0].id | https://openalex.org/keywords/telmisartan |
| keywords[0].score | 0.7361652851104736 |
| keywords[0].display_name | Telmisartan |
| keywords[1].id | https://openalex.org/keywords/endocrinology |
| keywords[1].score | 0.5993908047676086 |
| keywords[1].display_name | Endocrinology |
| keywords[2].id | https://openalex.org/keywords/combination-therapy |
| keywords[2].score | 0.5948556065559387 |
| keywords[2].display_name | Combination therapy |
| keywords[3].id | https://openalex.org/keywords/renal-function |
| keywords[3].score | 0.5737112760543823 |
| keywords[3].display_name | Renal function |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5680252909660339 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/pharmacology |
| keywords[5].score | 0.5658807754516602 |
| keywords[5].display_name | Pharmacology |
| keywords[6].id | https://openalex.org/keywords/aldosterone |
| keywords[6].score | 0.5553829669952393 |
| keywords[6].display_name | Aldosterone |
| keywords[7].id | https://openalex.org/keywords/plasma-renin-activity |
| keywords[7].score | 0.5165397524833679 |
| keywords[7].display_name | Plasma renin activity |
| keywords[8].id | https://openalex.org/keywords/creatinine |
| keywords[8].score | 0.5124288201332092 |
| keywords[8].display_name | Creatinine |
| keywords[9].id | https://openalex.org/keywords/kidney-disease |
| keywords[9].score | 0.5101495385169983 |
| keywords[9].display_name | Kidney disease |
| keywords[10].id | https://openalex.org/keywords/medicine |
| keywords[10].score | 0.48751017451286316 |
| keywords[10].display_name | Medicine |
| keywords[11].id | https://openalex.org/keywords/ace-inhibitor |
| keywords[11].score | 0.4155641496181488 |
| keywords[11].display_name | ACE inhibitor |
| keywords[12].id | https://openalex.org/keywords/renin–angiotensin-system |
| keywords[12].score | 0.38384518027305603 |
| keywords[12].display_name | Renin–angiotensin system |
| keywords[13].id | https://openalex.org/keywords/chemistry |
| keywords[13].score | 0.362109899520874 |
| keywords[13].display_name | Chemistry |
| keywords[14].id | https://openalex.org/keywords/urology |
| keywords[14].score | 0.32047417759895325 |
| keywords[14].display_name | Urology |
| keywords[15].id | https://openalex.org/keywords/blood-pressure |
| keywords[15].score | 0.28620219230651855 |
| keywords[15].display_name | Blood pressure |
| keywords[16].id | https://openalex.org/keywords/angiotensin-converting-enzyme |
| keywords[16].score | 0.2520042061805725 |
| keywords[16].display_name | Angiotensin-converting enzyme |
| language | en |
| locations[0].id | doi:10.1016/j.jphs.2016.01.003 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S163931769 |
| locations[0].source.issn | 1347-8613, 1347-8648 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1347-8613 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Pharmacological Sciences |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Pharmacological Sciences |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jphs.2016.01.003 |
| locations[1].id | pmid:26887332 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of pharmacological sciences |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/26887332 |
| locations[2].id | pmh:oai:doaj.org/article:a0568c95b4384664a6769932401155f7 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Journal of Pharmacological Sciences, Vol 130, Iss 2, Pp 110-116 (2016) |
| locations[2].landing_page_url | https://doaj.org/article/a0568c95b4384664a6769932401155f7 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5050086998 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1584-249X |
| authorships[0].author.display_name | Yuki Narita |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[0].affiliations[0].raw_affiliation_string | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I96036126 |
| authorships[0].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Kumamoto University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuki Narita |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[1].author.id | https://openalex.org/A5103069154 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3436-0018 |
| authorships[1].author.display_name | Miki Ueda |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I96036126 |
| authorships[1].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Kumamoto University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Miki Ueda |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[2].author.id | https://openalex.org/A5041356596 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2606-9762 |
| authorships[2].author.display_name | Kohei Uchimura |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210112011 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Internal Medicine III, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I4210112011 |
| authorships[2].institutions[0].ror | https://ror.org/022tqjv17 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210112011 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | University of Yamanashi Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kohei Uchimura |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Internal Medicine III, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan |
| authorships[3].author.id | https://openalex.org/A5020395320 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Yutaka Kakizoe |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I96036126 |
| authorships[3].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Kumamoto University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yutaka Kakizoe |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[4].author.id | https://openalex.org/A5086709276 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Yoshikazu Miyasato |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I96036126 |
| authorships[4].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Kumamoto University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yoshikazu Miyasato |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[5].author.id | https://openalex.org/A5024342076 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Teruhiko Mizumoto |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I96036126 |
| authorships[5].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Kumamoto University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Teruhiko Mizumoto |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[6].author.id | https://openalex.org/A5086853921 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6196-6023 |
| authorships[6].author.display_name | Jun Morinaga |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I96036126 |
| authorships[6].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Kumamoto University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Jun Morinaga |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[7].author.id | https://openalex.org/A5039094040 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-6123-5693 |
| authorships[7].author.display_name | Manabu Hayata |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I96036126 |
| authorships[7].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Kumamoto University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Manabu Hayata |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[8].author.id | https://openalex.org/A5110336396 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Terumasa Nakagawa |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I96036126 |
| authorships[8].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Kumamoto University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Terumasa Nakagawa |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[9].author.id | https://openalex.org/A5050460349 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-5139-2532 |
| authorships[9].author.display_name | Masataka Adachi |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I96036126 |
| authorships[9].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Kumamoto University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Masataka Adachi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[10].author.id | https://openalex.org/A5111503655 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Taku Miyoshi |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I96036126 |
| authorships[10].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Kumamoto University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Taku Miyoshi |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[11].author.id | https://openalex.org/A5063483183 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Yoshiki Sakai |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210112155 |
| authorships[11].affiliations[0].raw_affiliation_string | Research Headquarters, Ono Pharmaceutical Co., Ltd., 1-8-2 Kyutaromachi, Chuo-ku, Osaka, 541-8564, Japan |
| authorships[11].institutions[0].id | https://openalex.org/I4210112155 |
| authorships[11].institutions[0].ror | https://ror.org/022jefx64 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210112155 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Ono Pharmaceutical (Japan) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Yoshiki Sakai |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Research Headquarters, Ono Pharmaceutical Co., Ltd., 1-8-2 Kyutaromachi, Chuo-ku, Osaka, 541-8564, Japan |
| authorships[12].author.id | https://openalex.org/A5020836697 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5166-7145 |
| authorships[12].author.display_name | Daisuke Kadowaki |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[12].affiliations[0].raw_affiliation_string | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[12].institutions[0].id | https://openalex.org/I96036126 |
| authorships[12].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Kumamoto University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Daisuke Kadowaki |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[13].author.id | https://openalex.org/A5000897475 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-3064-1963 |
| authorships[13].author.display_name | Sumío Hirata |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[13].affiliations[0].raw_affiliation_string | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[13].institutions[0].id | https://openalex.org/I96036126 |
| authorships[13].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | Kumamoto University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Sumio Hirata |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan |
| authorships[14].author.id | https://openalex.org/A5030772606 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-5636-4039 |
| authorships[14].author.display_name | Masashi Mukoyama |
| authorships[14].countries | JP |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[14].institutions[0].id | https://openalex.org/I96036126 |
| authorships[14].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[14].institutions[0].country_code | JP |
| authorships[14].institutions[0].display_name | Kumamoto University |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Masashi Mukoyama |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan |
| authorships[15].author.id | https://openalex.org/A5033457244 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-8661-7658 |
| authorships[15].author.display_name | Kenichiro Kitamura |
| authorships[15].countries | JP |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210112011 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Internal Medicine III, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan |
| authorships[15].institutions[0].id | https://openalex.org/I4210112011 |
| authorships[15].institutions[0].ror | https://ror.org/022tqjv17 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210112011 |
| authorships[15].institutions[0].country_code | JP |
| authorships[15].institutions[0].display_name | University of Yamanashi Hospital |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Kenichiro Kitamura |
| authorships[15].is_corresponding | True |
| authorships[15].raw_affiliation_strings | Department of Internal Medicine III, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.jphs.2016.01.003 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11001 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Renin-Angiotensin System Studies |
| related_works | https://openalex.org/W2393759938, https://openalex.org/W2354469736, https://openalex.org/W943090989, https://openalex.org/W2363957081, https://openalex.org/W1550989882, https://openalex.org/W146935509, https://openalex.org/W2076569737, https://openalex.org/W2048806417, https://openalex.org/W2152798629, https://openalex.org/W2313406747 |
| cited_by_count | 13 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2021 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2020 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2019 |
| counts_by_year[4].cited_by_count | 3 |
| counts_by_year[5].year | 2018 |
| counts_by_year[5].cited_by_count | 2 |
| counts_by_year[6].year | 2017 |
| counts_by_year[6].cited_by_count | 1 |
| counts_by_year[7].year | 2016 |
| counts_by_year[7].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.jphs.2016.01.003 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S163931769 |
| best_oa_location.source.issn | 1347-8613, 1347-8648 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1347-8613 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Pharmacological Sciences |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Pharmacological Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jphs.2016.01.003 |
| primary_location.id | doi:10.1016/j.jphs.2016.01.003 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S163931769 |
| primary_location.source.issn | 1347-8613, 1347-8648 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1347-8613 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Pharmacological Sciences |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Pharmacological Sciences |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jphs.2016.01.003 |
| publication_date | 2016-01-20 |
| publication_year | 2016 |
| referenced_works | https://openalex.org/W2044773944, https://openalex.org/W2169506520, https://openalex.org/W2056976690, https://openalex.org/W2032425666, https://openalex.org/W6771638276, https://openalex.org/W1604542334, https://openalex.org/W2052392871, https://openalex.org/W2016627185, https://openalex.org/W2041648308, https://openalex.org/W2134749334, https://openalex.org/W2157438290, https://openalex.org/W1998910684, https://openalex.org/W2031948766, https://openalex.org/W2098684572, https://openalex.org/W2042641359, https://openalex.org/W2100409734, https://openalex.org/W2167078761, https://openalex.org/W2044115563, https://openalex.org/W2060853764, https://openalex.org/W2010444753, https://openalex.org/W2047882967, https://openalex.org/W1995538993, https://openalex.org/W1991456443, https://openalex.org/W2078894098, https://openalex.org/W1965287633, https://openalex.org/W2529012027, https://openalex.org/W2993043209, https://openalex.org/W2602549157 |
| referenced_works_count | 28 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5033457244 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| corresponding_institution_ids | https://openalex.org/I4210112011 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.84842839 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |